Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 6—June 2025

Dispatch

Dual-Genotype Orientia tsutsugamushi Infections, Hainan Island, China, 2023

Yi Niu1, Siqi Chen1, Gaoyu Wang, Yijia Guo, Nan Ge, Xiaoyuan Hu, Chuanning Tang, Ruoyan Peng, Xiuji Cui, Biao Wu, Bo Wang, Yueping Wang, Dachuan Lin, Yongguo Du, Jasper Fuk-Woo Chan, Long Sun, Kwok-Yung Yuen2, Liyuan Zhang2, and Feifei Yin2Comments to Author 
Author affiliation: Hainan Medical University, Haikou, China (Y. Niu, S. Chen, G. Wang, Y. Guo, N. Ge, X. Hu, C. Tang, R. Peng, X. Cui, B. Wu, B. Wang, Y. Wang, D. Lin, Y. Du, L. Sun, L. Zhang, F. Yin); University of Hong Kong, Hong Kong, China (J. F.-W. Chan, K.-Y. Yuen)

Main Article

Table

Clinical and laboratory features of patients in study of dual-genotype Orientia tsutsugamushi infections, Hainan, China, 2023*

Patient Age, y/sex Clinical status at admission Site of eschar Disease severity Genotypes (ratio) Hospital stay, d
1 55/M 5-day history of fever, headache, fatigue NA Moderate Karp_B + JG_C (1:2) 6
2 49/M 10-day history of fever, cough, dyspnea Below clavicle Severe (ICU) Karp_A + JG_C (17:2) 16
3 64/M 5-day history of ataxia, weakness (afebrile) Hip Severe (shock) Karp_B + Kato_B (1:1) 6

*ICU, intensive care unit; NA, not applicable.

Main Article

1These authors contributed equally to this article.

2These authors contributed equally to this article and are co–senior authors.

Page created: May 08, 2025
Page updated: May 27, 2025
Page reviewed: May 27, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external